Peter T Daley-Yates

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. ncbi request reprint Bioavailability and metabolism of mometasone furoate: pharmacology versus methodology
    Hartmut Derendorf
    College of Pharmacy, University of Florida, Gainesville 32610, USA
    J Clin Pharmacol 42:383-7. 2002
  2. ncbi request reprint Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays
    P T Daley-Yates
    GlaxoSmithKline Research and Development, Clinical Pharmacology and Discovery Medicine, Greenford Road, UB6 0HE Greenford, Middlesex, UK
    Eur J Clin Pharmacol 60:265-8. 2004
  3. doi request reprint The efficacy and tolerability of two novel H(1)/H(3) receptor antagonists in seasonal allergic rhinitis
    Peter Daley-Yates
    GlaxoSmithKline, Research and Development, Uxbridge, UK
    Int Arch Allergy Immunol 158:84-98. 2012
  4. ncbi request reprint Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model
    Peter T Daley-Yates
    GlaxoSmithKline Research and Development, Greenford Road, Greenford, UB6 OHE, UK
    Clin Ther 26:1905-19. 2004
  5. doi request reprint Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone propiona
    Peter T Daley-Yates
    GlaxoSmithKline, Stockley Park, Middlesex, United Kingdom
    Clin Ther 31:370-85. 2009
  6. doi request reprint Establishing bioequivalence for inhaled drugs; weighing the evidence
    Peter T Daley-Yates
    GlaxoSmithKline, Respiratory Medicines Discovery and Development, Stockley Park, Middlesex UB11 1BT, UK
    Expert Opin Drug Deliv 8:1297-308. 2011
  7. ncbi request reprint Hypothalamic-pituitary-adrenal axis function after inhaled corticosteroids: unreliability of urinary free cortisol estimation
    Richard S Fink
    Chemical Pathology Department, West Middlesex University Hospital Quest Diagnostics, Inc, Isleworth, Middlesex, United Kingdom TW7 6AF
    J Clin Endocrinol Metab 87:4541-6. 2002

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Bioavailability and metabolism of mometasone furoate: pharmacology versus methodology
    Hartmut Derendorf
    College of Pharmacy, University of Florida, Gainesville 32610, USA
    J Clin Pharmacol 42:383-7. 2002
    ..Reliable estimates of systemic drug exposure are critical in evaluating the real safety profiles and therapeutic index for inhaled corticosteroids that are effective in treating chronic asthma...
  2. ncbi request reprint Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays
    P T Daley-Yates
    GlaxoSmithKline Research and Development, Clinical Pharmacology and Discovery Medicine, Greenford Road, UB6 0HE Greenford, Middlesex, UK
    Eur J Clin Pharmacol 60:265-8. 2004
    ..To compare the systemic exposure for intranasal mometasone furoate (MF) and fluticasone propionate (FP) aqueous nasal sprays (ANS) in terms of serum and urinary cortisol parameters and plasma pharmacokinetics...
  3. doi request reprint The efficacy and tolerability of two novel H(1)/H(3) receptor antagonists in seasonal allergic rhinitis
    Peter Daley-Yates
    GlaxoSmithKline, Research and Development, Uxbridge, UK
    Int Arch Allergy Immunol 158:84-98. 2012
    ..Combined H(1)/H(3) blockade has therefore been investigated as a novel therapeutic approach that may enhance symptom relief, particularly nasal blockage...
  4. ncbi request reprint Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model
    Peter T Daley-Yates
    GlaxoSmithKline Research and Development, Greenford Road, Greenford, UB6 OHE, UK
    Clin Ther 26:1905-19. 2004
    ....
  5. doi request reprint Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone propiona
    Peter T Daley-Yates
    GlaxoSmithKline, Stockley Park, Middlesex, United Kingdom
    Clin Ther 31:370-85. 2009
    ..However, there is considerable debate concerning the extent to which DPIs are interchangeable without altering disease control or the safety profile of the treatment...
  6. doi request reprint Establishing bioequivalence for inhaled drugs; weighing the evidence
    Peter T Daley-Yates
    GlaxoSmithKline, Respiratory Medicines Discovery and Development, Stockley Park, Middlesex UB11 1BT, UK
    Expert Opin Drug Deliv 8:1297-308. 2011
    ....
  7. ncbi request reprint Hypothalamic-pituitary-adrenal axis function after inhaled corticosteroids: unreliability of urinary free cortisol estimation
    Richard S Fink
    Chemical Pathology Department, West Middlesex University Hospital Quest Diagnostics, Inc, Isleworth, Middlesex, United Kingdom TW7 6AF
    J Clin Endocrinol Metab 87:4541-6. 2002
    ..Many of the published studies describing or comparing the safety of different ICS should be reevaluated, and some should be interpreted with caution...